Search details
1.
Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics.
Hum Mol Genet
; 30(24): 2469-2487, 2021 11 30.
Article
in English
| MEDLINE | ID: mdl-34296279
2.
Human-induced pluripotent stem cells: potential for neurodegenerative diseases.
Hum Mol Genet
; 23(R1): R17-26, 2014 Sep 15.
Article
in English
| MEDLINE | ID: mdl-24824217
3.
Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease.
Nat Commun
; 8: 14405, 2017 02 13.
Article
in English
| MEDLINE | ID: mdl-28194040
4.
PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically.
Nat Med
; 22(1): 37-45, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26642438
5.
Bypass of senescence, immortalization, and transformation of human hematopoietic progenitor cells.
Stem Cells
; 23(9): 1423-33, 2005 Oct.
Article
in English
| MEDLINE | ID: mdl-16144874
6.
Opposing roles of Ras/Raf oncogenes and the MEK1/ERK signaling module in regulation of expression and adhesive function of surface transglutaminase.
J Biol Chem
; 278(37): 35609-19, 2003 Sep 12.
Article
in English
| MEDLINE | ID: mdl-12832399
7.
Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis.
Biochemistry
; 43(37): 11760-9, 2004 Sep 21.
Article
in English
| MEDLINE | ID: mdl-15362860
Results
1 -
7
de 7
1
Next >
>>